Please login to the form below

Not currently logged in
Email:
Password:

Alios BioPharna

This page shows the latest Alios BioPharna news and features for those working in and with pharma, biotech and healthcare.

Johnson & Johnson to acquire Alios BioPharma for $1.75bn

Johnson & Johnson to acquire Alios BioPharma for $1.75bn

Johnson &Johnson has acquired California-based clinical stage biopharma company Alios BioPharma for $1.75bn. ... The acquisition will include Alios BioPharma's preclinical programmes that target influenza and rhinovirus, as well as RSV.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
foxandcat.online

We help communications teams to thrive under pressure. Here at fox&cat, we help all kinds of teams to fight all...

Latest intelligence

Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...